未登录
分享
收藏
分享
收藏
分享
收藏Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program体重指数未影响依特拉西莫德的有效性和安全性:ELEVATE UC 临床项目的事后分析
Yarur, Andres J.; Long, Millie D.; Torres, Joana; Nandi, Neilanjan; Cross, Raymond K.; Abbatemarco, Arcangelo M.; Blanco, David; Niezychowski, Wojciech; Crosby, Catherine; Wu, Joseph; Pradeep, Gokul; Goetsch, Martina; Panaccione, Remo
分享
收藏Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age奥扎尼妥(Ozanimod)在按年龄分层的中度至重度活动性溃疡性结肠炎患者中的安全性与有效性
Faye, Adam S.; Rubin, David T.; Siegel, Corey A.; Long, Millie D.; Khan, Nabeel; Danese, Silvio; Irving, Peter M.; Cross, Raymond K.; Blumenstein, Irina; Armuzzi, Alessandro; Horst, Sara N.; Dignass, Axel; Kobayashi, Taku; Lawlor, Garrett; Krakovich, Anthony; Petersen, Annkatrin; Liu, Zhaohui; Wang, Dong; Jain, Anjali; Ananthakrishnan, Ashwin N.; Sabino, Joao
分享
收藏
分享
收藏An Update on a Multi-Center, Prospective, Non-Interventional Study of the Real-World Effectiveness of Etrasimod in Patients With Ulcerative Colitis (ENDEAVOUR-UC) Living in the United States关于在美国居住的溃疡性结肠炎患者中,关于依特拉司莫德真实世界有效性的多中心、前瞻性、非干预性研究(ENDEAVOUR-UC)的更新
Axelrad, Jordan; Herfarth, Hans; Rimon, Sharon; Cognata, Christina; Hur, Peter; Binder, Elke; Gruben, David; Kulisek, Nicole; Long, Millie D.
分享
收藏Pharmacokinetics and Exposure-Response Relationships of Guselkumab Intravenous or Subcutaneous Induction in Participants With Ulcerative ColitisGuselkumab静脉或皮下诱导给药在溃疡性结肠炎患者中的药代动力学及暴露-反应关系
Peyrin-Biroulet, Laurent; Xu, Zhenhua; Shao, Jie; Hisamatsu, Tadakazu; Long, Millie D.; Danese, Silvio; Germinaro, Matthew; Vetter, Marion L.; Yarandi, Shadi; Baker, Thomas; Allegretti, Jessica R.; Rubin, David T.
分享
收藏Missing the Mark: Treat-to-Target Gaps in Real-World Ulcerative Colitis Care未达标:真实世界中溃疡性结肠炎治疗目标存在的差距
Long, Millie D.; Salinas, Yasmmyn D.; Bufford, Teresa; Crawford, Julie M.; Gazis, Derek R.; Hurwitz, Kathleen; Igho-Osagie, Ebuwa; Liu, Gui; Shao, Jeremy; Sands, Bruce E.
分享
收藏Predictors of Response to Ustekinumab and Identification of Factors Associated With Dose Escalation in Patients With Inflammatory Bowel Disease乌司奴单抗治疗应答的预测因子及炎症性肠病患者剂量加倍的关联因素识别
Axelrad, Jordan; Horst, Sara; Bennett, Audrey; Ashokan, Anagha; Hudhud, Dania; Wu, Angela; Long, Millie D.; Anderson, Chelsea; Chaudhary, Vasantham; Axenfeld, Ellen M.; Cross, Raymond K.
分享
收藏
分享
收藏
分享
收藏
分享
收藏Impact of Subcutaneous Guselkumab Induction Therapy on Molecular Inflammation in Patients With Ulcerative Colitis: Results From the Phase 3 ASTRO Study皮下注射古塞库单抗诱导治疗对溃疡性结肠炎患者分子炎症的影响:ASTRO III期研究结果
Venkat, Swati; Sridhar, Sunandini; Shaikh, Barbara; Sohn, Klebea; Liu, Jared; Sisk, Christopher; McRae, Bradford; Alvarez, Yelinia; Baker, Thomas; Germinaro, Matthew; Allegretti, Jessica R.; Long, Millie D.; Rubin, David T.; Peyrin-Biroulet, Laurent; Hart, Amy; Branigan, Patrick
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏P0894 Impact of Mirikizumab on Extraintestinal Manifestations of Crohn's Disease in the VIVID-1 Study
Vavricka, S. R.; Ananthakrishnan, A.; Long, M.; Melmed, G.; Narula, N.; Rubin, D.; Hon, E.; Carlier, H.; Moses, R.; Yu, G.; Zang, H.; Kucharzik, T.
分享
收藏
分享
收藏